You are here

Abattis Bioceuticals Corp.

Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
ATT
CSE Index: 
Currency: 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

You are here

Abattis Bioceuticals Corp. (ATT)

SEDAR Information

Company Info

Address
1200 - 625 Howe Street
Vancouver, BC V6C 2M6
Canada
Phone
604-674-8232
Email
news@abattis.com
Website
http://www.abattis.com
Listing date
Thursday, December 23, 2010
Transfer Agent
Computershare Investor Services Inc.
Auditor
DALE MATHESON CARR-HILTON LABONTE LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
352,529,829
Reserved for Issuance: 
0

Bulletins

04/02/2019

2019-0206 - Suspension - Abattis Bioceuticals Corp. (ATT)

Le 4 février/February 2019

Abattis Bioceuticals Corp.  is in default of CSE requirements. Effective immediately, Abattis Bioceuticals will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.  A cease trade order has been issued by the Ontario Securities Commission and the British Columbia Securities Commission.

Advertisement

Publicité

Latest CSE News

Upcoming Events

05_28_Issues_Changes_Capital_Markets_Website

CSE Talks Issues & Changes in the Capital Markets

Tuesday, May 28, 2019 -
2:45pm to 5:00pm
06_04_2019_ACA_Northwest_Website

2019 ACA Northwest Regional Meeting

Tuesday, June 4, 2019 (All day) to Wednesday, June 5, 2019 (All day)
06_05_TakeStock_Alberta_Website_v2

TakeStock Alberta

Wednesday, June 5, 2019 -
8:30am to 5:30pm